Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Ayse, Salihoglu"'
Publikováno v:
Diagnostics, Vol 14, Iss 11, p 1167 (2024)
The aim of this study is to investigate whether there is a cut-off value for PD-L1 expression in large B-cell lymphomas that predicts prognosis, and to clarify the relationship between PD-L1 expression and histopathological as well as clinical parame
Externí odkaz:
https://doaj.org/article/5140809e82344b5489bb5e5c19223c68
Autor:
Ayse Salihoglu, Yildiz Aydin, Ozden Hatirnaz, Ahmet Emre Eskazan, Ugur Ozbek, Şeniz Öngören, Zafer Baslar, Tugrul Elverdi, Muge Sayitoglu, Teoman Soysal, Muhlis Cem Ar, Isil Erdogan Ozunal
Publikováno v:
Cerrahpasa Medical Journal. 45:221-226
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ecdd6a71c7899dcb141b5fa3a349b7c
https://doi.org/10.5152/cjm.2021.21021
https://doi.org/10.5152/cjm.2021.21021
Autor:
Tuba Ozkan Tekin, Sercan Olcar, Suleyman Sami Guzel, Ayse Salihoglu, Muveddet Rezzan Ataman, Ahmet Murt
Publikováno v:
Seminars in Dialysis. 35:96-99
Vancomycin is one of the drugs used in the peritonitis treatment regimen of peritoneal dialysis patients. Intraperitoneal route is generally preferred to provide rapid elimination of infective agents. Systemic toxicities of certain drugs after intrap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c4b82f4b501d785e79af1bf07b3d443
https://doi.org/10.1111/sdi.13024
https://doi.org/10.1111/sdi.13024
Publikováno v:
Drug Design, Development and Therapy
Follicular lymphoma (FL) is an indolent (low-grade) malignancy of B cells and is among the most common hematological cancers affecting adults. Its clinical presentation, natural course, and severity are highly variable. Management of FL depends on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4add62d18f78c00c0a61ac4388065032
http://europepmc.org/articles/PMC8434836
http://europepmc.org/articles/PMC8434836
Autor:
Ali Tunc, Murad Guliyev, Tuba Özkan Tekin, Selin Kucukyurt, Umut Yilmaz, Eda Kantarci, Damla Ortaboz, Tuğrul Elverdi, Ahmet Emre Eşkazan, Şeniz Öngören, Muhlis Cem Ar, Zafer Başlar, Yildiz Aydin, Ayse Salihoglu
Publikováno v:
Blood. 140:12518-12519
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d17b3bdfe2612a112efc4f0956747b83
https://doi.org/10.1182/blood-2022-170159
https://doi.org/10.1182/blood-2022-170159
Autor:
Duygu Seyhan Erdoğan, Gülçin Benbir Şenel, Ayşegül Gündüz, Beria Peren Uçar, Tuğrul Elverdi, Ayse Salihoglu, Muhlis Cem Ar, Şeniz Öngören, Zafer Başlar, Ahmet Emre Eşkazan
Publikováno v:
Blood. 140:12278-12279
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::273ab8ea46b1dc47171fb7132ed6eedc
https://doi.org/10.1182/blood-2022-167347
https://doi.org/10.1182/blood-2022-167347
Autor:
Fevzi Firat Yalniz, Ahmet Emre Eskazan, Ugur Ozbek, Şeniz Öngören, Hulya Yilmaz, Ozden Hatirnaz Ng, Teoman Soysal, Ayse Salihoglu, Tugce Sudutan, M. Cem Ar, Emrah Yücesan, Muge Sayitoglu, Zafer Baslar
Publikováno v:
Expert Review of Hematology. 13:1277-1287
Objectives Immune thrombocytopenia (ITP) is an autoimmune disease with heterogeneous background. FCGR2C mutations were defined in one third of the patients but genetic players have not been fully elucidated yet. Although childhood ITP present as beni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9257cab8d6328625c4b39c4cc58e5b7a
https://doi.org/10.1080/17474086.2020.1819786
https://doi.org/10.1080/17474086.2020.1819786
Autor:
Zafer Baslar, Muhlis Cem Ar, Teoman Soysal, Ahmet Murt, Ayse Salihoglu, Ahmet Emre Eskazan, Şeniz Öngören, Tugrul Elverdi
Publikováno v:
Annals of Hematology
Hematopoietic stem cell transplantation (HSCT) is a risk factor for viral hepatitis reactivations because it affects lymphocyte number and functions. Latent hepatitis B virus (HBV) may stay in dormant form in hepatocytes and may be reactivated in pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b0c470f280d0d369f845b8e83f410ba
https://doi.org/10.1007/s00277-020-04206-z
https://doi.org/10.1007/s00277-020-04206-z
Autor:
Mutlu, Deniz, Ayse, Salihoglu, Esen, Beril Kara, Rempakos, Athanasios, Alexandrou, Michaella, Yalin, Kivanc, Avci, Burcak Kilickiran
Publikováno v:
In Journal of the American College of Cardiology 2 April 2024 83(13) Supplement:1392-1392
Autor:
Teoman Soysal, Semra Paydas, Nuri Karadurmus, Elif Birtas, Murat Ozbalak, Hakan Goker, Birol Yildiz, Vildan Ozkocaman, Muhit Ozcan, Pervin Topcuoglu, Ayse Salihoglu, Burhan Ferhanoglu, Evren Ozdemir, Münci Yağcı, Leylagül Kaynar, Ihsan Karadogan
Publikováno v:
Annals of Hematology. 99:301-307
Classical Hodgkin lymphoma (cHL) is considered a curable disease; however, approximately one-third of responders experience disease relapse following first-line therapy. Several studies have shown the efficacy of brentuximab vedotin (BV) in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6aea850b32809621c52214b62a20362
https://doi.org/10.1007/s00277-019-03899-1
https://doi.org/10.1007/s00277-019-03899-1